Rodman David Malcom
Chief Medical Officer
Rodman David Malcom has filed 24 SEC Form 4 filings (88 transaction rows) across 1 company, with disclosures dating back to 2025. 22 of those filings fall inside the rolling window. Most recent filing: Aug 12, 2026.
On the most recent filing, Rodman David Malcom is listed as Chief Medical Officer at Mineralys Therapeutics, Inc. Inside the rolling window, Rodman David Malcom reported no open-market purchases and 32 open-market sales totaling $14.0M in MLYS. The largest disclosed transaction in the window is a sale of 192,715 MLYS shares on Jan 5, 2026, worth $6.7M.
Companies traded
Other insiders at MLYS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$14.0M
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| MLYS | Chief Medical Officer | Sale | 2,170 | $59K | Aug 12 | SEC ↗ | |
| MLYS | Chief Medical Officer | Sale | 416 | $11K | Jul 21 | SEC ↗ | |
| MLYS | Chief Medical Officer | Sale | 14,058 | $388K | Jul 16 | SEC ↗ | |
| MLYS | Chief Medical Officer | Sale | 6,349 | $169K | Jul 16 | SEC ↗ | |
| MLYS | Chief Medical Officer | Sale | 2,171 | $66K | Jul 10 | SEC ↗ | |
| MLYS | Chief Medical Officer | Sale | 9,890 | $235K | Jun 18 | SEC ↗ | |
| MLYS | Chief Medical Officer | Sale | 4,584 | $115K | Jun 18 | SEC ↗ | |
| MLYS | Chief Medical Officer | Sale | 2,170 | $54K | Jun 12 | SEC ↗ | |
| MLYS | Chief Medical Officer | Sale | 6,349 | $152K | Jun 12 | SEC ↗ | |
| MLYS | Chief Medical Officer | Sale | 417 | $11K | May 19 | SEC ↗ | |
| MLYS | Chief Medical Officer | Sale | 2,171 | $65K | May 14 | SEC ↗ | |
| MLYS | Chief Medical Officer | Sale | 6,348 | $186K | May 14 | SEC ↗ | |
| MLYS | Chief Medical Officer | Sale | 14,056 | $402K | May 14 | SEC ↗ | |
| MLYS | Chief Medical Officer | Sale | 416 | $13K | Apr 21 | SEC ↗ | |
| MLYS | Chief Medical Officer | Sale | 14,058 | $373K | Apr 15 | SEC ↗ | |
| MLYS | Chief Medical Officer | Sale | 6,348 | $176K | Apr 15 | SEC ↗ | |
| MLYS | Chief Medical Officer | Sale | 2,170 | $59K | Apr 13 | SEC ↗ | |
| MLYS | Chief Medical Officer | Sale | 417 | $11K | Mar 17 | SEC ↗ | |
| MLYS | Chief Medical Officer | Sale | 6,348 | $174K | Mar 16 | SEC ↗ | |
| MLYS | Chief Medical Officer | Sale | 14,058 | $369K | Mar 16 | SEC ↗ | |
| MLYS | Chief Medical Officer | Sale | 2,171 | $58K | Mar 10 | SEC ↗ | |
| MLYS | Chief Medical Officer | Sale | 417 | $12K | Feb 17 | SEC ↗ | |
| MLYS | Chief Medical Officer | Sale | 6,349 | $184K | Feb 13 | SEC ↗ | |
| MLYS | Chief Medical Officer | Sale | 14,055 | $386K | Feb 13 | SEC ↗ | |
| MLYS | Chief Medical Officer | Sale | 2,171 | $66K | Feb 11 | SEC ↗ |
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
Frequently asked questions
How many SEC Form 4 filings has Rodman David Malcom made?
Rodman David Malcom has filed 24 SEC Form 4 filings (88 transaction rows) across 1 company since 2025.
Which companies does Rodman David Malcom trade?
Rodman David Malcom has filed SEC Form 4 disclosures for 1 company, including MLYS.
When was Rodman David Malcom's most recent SEC Form 4 filing?
Rodman David Malcom's most recent SEC Form 4 filing on Tracefour is dated Aug 12, 2026.
What is Rodman David Malcom's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Rodman David Malcom is listed as Chief Medical Officer.
What is Rodman David Malcom's total buy and sell value in the current window?
Inside the rolling retention window, Rodman David Malcom bought $0 and sold $14.0M based on SEC Form 4 filings.
What was Rodman David Malcom's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 192,715 MLYS shares on 2026-01-05, worth $6.7M, per SEC Form 4 filings.